MESQUITE REHABILITATION INSTITUTE — History
CCN 673045 | 3-year financial timeline | COVID resilience: 49/100
🛡️ Public data only — no PHI permitted on this instance.
$15M
Latest Revenue (FY2022)
+11.7%
Revenue CAGR (3yr)
13.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $12M | $14M | $15M | +6.6% | +11.7% |
| Operating Expenses | $9M | $12M | $13M | +8.7% | +19.0% |
| Operating Margin | 23.6% | 15.0% | 13.4% | -10.9% | -24.8% |
| Net Income | $3M | $2M | $2M | -5.0% | -16.0% |
| Licensed Beds | 30 | 30 | 30 | +0.0% | +0.0% |
| Total Patient Days | 7,773 | 8,526 | 9,110 | +6.8% | +8.3% |
| Medicare Day % | 71% | 63% | 63% | +0.1% | -5.8% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 49/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +24.8% ($12M → $15M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+11.7%
This Hospital
+7.6%
State Avg
Latest Margin
13.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $17M | 8.2% |
| FY2024 (proj) | $18M | 3.1% |
| FY2025 (proj) | $20M | -2.0% |